Skip to main content

Table 1 Summary of respondent characteristics, comparison of estimation and validation datasets

From: Using the Fatigue Severity Scale to inform healthcare decision-making in multiple sclerosis: mapping to three quality-adjusted life-year measures (EQ-5D-3L, SF-6D, MSIS-8D)

 

All baseline data

Estimation dataset

Validation dataset

Differencea

 

Mean

SD

Observations

Mean

SD

Observations

Mean

SD

Observations

t statistic

p value

Measure

 FSS

43.73

15.10

1054

43.44

15.16

787

44.60

14.91

267

−1.085

0.278

 EQ-5D

0.596

0.295

1346

0.600

0.291

1005

0.584

0.309

341

0.831

0.406

 SF-6D

0.646

0.130

632

0.650

0.135

473

0.636

0.113

159

1.141

0.254

 MSIS-8D

0.646

0.185

690

0.647

0.190

523

0.641

0.172

167

0.412

0.681

Characteristic

 Age

50.67

11.68

1400

50.74

11.73

1048

50.45

11.54

352

0.402

0.688

 Duration (years)

9.62

10.01

1347

9.61

10.00

1009

9.68

10.09

338

−0.113

0.910

 EDSS score

4.30

2.31

289

4.32

2.34

218

4.22

2.24

71

0.324

0.746

 

Percentage

Observations

Percentage

Observations

Percentage

Observations

chi2 statistic

p value

Gender

 Female

73.86%

1040

74.62%

788

71.59%

252

1.256

0.262

 Male

26.14%

368

25.38%

268

28.41%

100

  

MS type

 Relapsing remitting

41.97%

572

42.66%

439

39.82%

133

7.572

0.109

 Primary progressive

19.37%

264

18.56%

191

21.86%

73

  

 Secondary progressive

16.95%

231

17.69%

182

14.67%

49

  

 Benign

3.3%

45

3.69%

38

2.10%

7

  

 DK or combination

18.42%

251

17.40%

179

21.56%

72

  

 Missing

 

45

 

27

 

18

  

Recent relapseb

 Yes

53.55%

732

53.42%

546

53.91%

186

0.025

0.988

 No

33.28%

455

33.37%

341

33.04%

114

  

 Don’t know

13.17%

180

13.21%

135

13.04%

45

  

 Missing

 

41

 

34

 

7

  
  1. SD standard deviation, FSS Fatigue Severity Scale, EQ-5D EuroQoL EQ-5D-3L, SF-6D Short-Form 6D, MSIS-8D Multiple Sclerosis Impact Scale – Eight Dimensions, EDSS Expanded Disability Status Scale, DK don’t know
  2. aDifference between estimation and validation datasets
  3. bRelapse in the 12 months prior to completing the baseline questionnaire
  4. nb response numbers are lower for the SF-6D and the MSIS-8D as only version 2 of these questionnaires were included